Immunologic changes during pandemic (H1N1) 2009, China

Emerging Infectious Diseases

Volumn 17, Issue 6, 2011, Pages 1053-1055

  Shen, Hong Hui ^a   Hou, Jun ^a   Chen, Wei Wei ^a   Bai, Bing Ke ^a   Wang, Hai Bin ^a   Guo, Tong Sheng ^a   Liu, Ai Xia ^a   Li, Yong Li ^a   Zhao, Min ^a   Mao, Pan Yong ^a   Li, Jin ^a   Li, Bo An ^a   Mao, Yuan Li ^a  

^a BEIJING 302 HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HEMAGGLUTINATION INHIBITING ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 6; VIRUS ANTIBODY;

2009 H1N1 INFLUENZA; ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; B LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHINA; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE COUNT; NATURAL KILLER CELL; PROTEIN BLOOD LEVEL;

EID: 79957632508     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid/1706.100643     Document Type: Article

References (12)

1. Centers for Disease Control and Prevention. Swine influenza A (H1N1) infection in two children-Southern California, March-April 2009. MMWR Morb Mortal Wkly Rep. 2009;58:400-402.
2. Centers for Disease Control and Prevention. Outbreak of swineorigin influenza A (H1N1) virus infection-Mexico, March-April 2009. MMWR Morb Mortal Wkly Rep. 2009;58:467-470.
3. Cao B, Li XW, Mao Y, Wang J, Lu HZ, Chen YS, et al. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med. 2009;361:2507-2517. doi:10.1056/NEJMoa0906612
4. Giamarellos-Bourboulis EJ, Raftogiannis M, Antonopoulou A, Bazaiaka F, Koutoukas P, Savva A, et al. Effect of the novel influenza A (H1N1) virus in the human immune system. PLoS ONE. 2009;4:e8393. doi:10.1371/journal.pone.0008393
5. Bermejo-Martin JF, Ortiz de Lejarazu R, Pumarola T, Rello J, Almansa R, Ramirez P, et al. Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. Crit Care. 2009;13:R201. doi:10.1186/cc8208
6. Hayden FG, Fritz R, Lobo MC, Alvord W, Strober W, Straus SE. Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest. 1998;101:643-649. doi:10.1172/JCI1355
7. Kaiser L, Fritz RS, Straus SE, Gubareva L, Hayden FG. Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses. J Med Virol. 2001;64:262-268. doi:10.1002/jmv.1045
8. Van Reeth K. Cytokines in the pathogenesis of influenza. Vet Microbiol. 2000;74:109-116. doi:10.1016/S0378-1135(00)00171-1
9. Sheng WH, Chiang BL, Chang SC, Ho HN, Wang JT, Chen YC, et al. Clinical manifestations and inflammatory cytokine responses in patients with severe acute respiratory syndrome. J Formos Med Assoc. 2005;104:715-23.
10. Kobasa D, Jones SM, Shinya K, Kash JC, Copps J, Ebihara H, et al. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature. 2007;445:319-323. doi:10.1038/nature05495
11. Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, Hatta M, et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature. 2009;460:1021-1025.
12. Zhu FC, Wang H, Fang HH, Yang JG, Lin XJ, Liang XF, et al. A novel influenza A (H1N1) vaccine in various age groups. N Engl J Med. 2009;361:2414-2423. doi:10.1056/NEJMoa0908535